Newly issued US patent covers key step in the exosome manufacturing process Oxford, United Kingdom, May 17, 2023 — Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announced that the Company has been granted another US patent adding to its growing manufacturing IP portfolio. Evox has been granted US Patent … Read more The post Evox Therapeutics Granted Key US Exosome Purification Patent to Further Expand Its Leading Patent Portfolio appeared first on Evox Therapeutics .